for Jul 02, 2020
Hallelujah HCQ works for a US academic center!!! Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19 - International Journal of Infectious Diseases https://t.co/OsSYga3ncv
— Dr. Urso (@richardursomd) July 2, 2020
“What a uniquely American tragedy where we have the most public health resources and we have one of the worst ... responses to this pandemic,” @BhadeliaMD says, as the US tops 50,000 new coronavirus cases in a single day. https://t.co/i7VwlppEwM
— MSNBC (@MSNBC) July 2, 2020
The top US expert in infectious diseases, Dr Anthony Fauci, spoke to @JustinOnWeb and expressed his concern over the rise in coronavirus cases in the country, warning of the risk of a greater outbreak if the latest surge is not controlled#R4Today podcasthttps://t.co/VpCATzhokS
— BBC Radio 4 Today (@BBCr4today) July 2, 2020
Infectious diseases doctor calls for national virus strategy https://t.co/srinTicfDa
— Morning Joe (@Morning_Joe) July 2, 2020
📍The rate at which the coronavirus infection is spreading in Denmark has increased since country opened schools & kindergartens, says 🇩🇰infectious diseases agency @SSI_dk. R from 0.6 to 0.9, but still below crucial figure of 1. But need vigilance. https://t.co/128WmuItr5
— Eric Feigl-Ding (@DrEricDing) July 2, 2020
NEW #ofid
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) July 2, 2020
The 1st systematic literature review and meta-analysis evaluate the association between ID Consultation & Candidemia mortality. IDC was associated with significantly ⬇️ mortality & should be considered in all patients with candidemia. #IDTwitter https://t.co/UXOlcl5OEF pic.twitter.com/q4eW0MIITb
Early Release - Large SARS-CoV-2 Outbreak Caused by Asymptomatic Traveler, China - Volume 26, Number 9—September 2020 - Emerging Infectious Diseases journal - CDC https://t.co/hEiaeh74JZ
— Dr. Saskia Popescu (@SaskiaPopescu) July 2, 2020
Peer Reviewed
— Peter M Mahahead (@petermmahahead) July 2, 2020
"13% of those treated with hydroxychloroquine alone died compared to 26.4% not treated with hydroxychloroquine"
"The study was published today in the International Journal of Infectious Diseases." @Jordan_Sather_ @martingeddes https://t.co/4zY08DkwMD
Following the publication of the @WHO's latest Global Antimicrobial Resistance and Use Surveillance System (GLASS) report, we caught up with @HananBalkhy
— BSAC (@BSACandJAC) July 2, 2020
to find out how data from the report will be used https://t.co/aUXkBi3Dsn #AMR #AntibioticResistance pic.twitter.com/d4ZQWRdf4y
NEW #ofid by @lncwengros
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) July 2, 2020
Minimizing time to optimal antimicrobial therapy for Enterobacteriaceae bloodstream infections: A retrospective, hypothetical application of predictive scoring tools versus rapid diagnostics tests. @TimbrookTT #IDTwitter https://t.co/b0mjk6tfXz
Recent study suggests that many people who contract #SARSCoV2 but have mild or no clinical signs still develop T-cell-mediated immunity to the #coronavirus, even in the absence of a positive antibody test.https://t.co/VgsbfzI3DT #COVID19
— Microbes&Infection (@MicrobesInfect) July 2, 2020
New minireview in #IAIJournal: Fitness Trade-Offs Resulting from Bacteriophage Resistance Potentiate Synergistic Antibacterial Strategies https://t.co/IZ5nOAp6Op pic.twitter.com/CoQVsBtDVX
— ASM (@ASMicrobiology) July 2, 2020
Coronavirus cases are peaking again, but it’s different this time. Excellent article in @NYTimes https://t.co/sfwMbl5cVf
— Carlos del Rio (@CarlosdelRio7) July 2, 2020
Live updates: @GovAbbott issues mandatory mask policy for counties with 20 or more coronavirus cases. Good for Texas, time for GA to do the same. It is only a face cover, you can do it @GovKemp https://t.co/sIxbvAHnHs
— Carlos del Rio (@CarlosdelRio7) July 2, 2020
Distribution of Transmission Potential during Non-Severe COVID-19 Illness https://t.co/w5lfg50ZXj. Elegant study from @ClevelandClinic suggesting in non-severe COVID-19, viral loads in upper resp specimens peak by 2-3 days from symptom onset and decrease rapidly thereafter.
— Carlos del Rio (@CarlosdelRio7) July 2, 2020
B. thetaiotaomicron, one of the most abundant bacteria in the mammalian intestine, produces eight surface-exposed polysaccharidic layers that mediate interactions with the gut and is a determinant of biofilm formation. @mBiojournal https://t.co/NxhJKgJNM9 pic.twitter.com/IiDieEKeWS
— ASM (@ASMicrobiology) July 2, 2020
Applying antimicrobial stewardship principles in treating #COVID19 patients can help avoid exacerbating #AntimicrobialResistance #AMR. See #AMRNews https://t.co/DLNyYRIET7 pic.twitter.com/TgWJBH7SLV
— South Centre (@South_Centre) July 2, 2020
3 months ago, infectious diseases experts urged the government to release people from immigration detention to avoid the risk of a COVID-19 outbreak.
— Hannah Ryan (@HannahD15) July 2, 2020
Now the Ombudsman says the number of detainees has gone UP during corona — because fewer deportations.https://t.co/Hb5LujD3mi
😷Dr. William Schaffner, a @VUMChealth #InfectiousDiseases expert, reviewed this @medrxivpreprint article & called it “rigorous, careful, controlled analysis” that “affirmed” current #mask mandates - both in #Virginia & internationally. #MaskUp #WearAMask https://t.co/zwUG6E0GSD pic.twitter.com/ChB4wy58Ro
— Dr. Melvin Sanicas 🩺🔬 (@Vaccinologist) July 2, 2020
Could a synthetic antibody prevent and treat #COVID19?
— Microbes&Infection (@MicrobesInfect) July 2, 2020
Researchers have developed an antibody that inhibits binding of the #coronavirus to its receptor, ACE2, thus preventing infection.https://t.co/ROSKM1nzmz
"Experts now believe that the spread of drug-resistant bacteria is probably the single greatest threat to society – greater even than the dangers posed by global terrorism, climate change and anything you’ll see at the cinema." https://t.co/Q2SMiCm2je #AntibioticResistance
— Battle Superbugs (@battlesuperbugs) July 2, 2020
Statewide & regional antibiograms may be effective strategies in targeting antibiotic resistance & should be considered valuable assets in regional #antimicrobialstewardship endeavors, according to Letter to the Editor published in ICHE https://t.co/rIH7Dv7859 pic.twitter.com/3L9joxZakE
— ICHE Journal (@ICHEJournal) July 2, 2020
Excited that our paper on the effect of individual actions in mitigating COVID-19 spread is now out in Clinical Infectious Diseases. Bottom line: keep up the masking, distancing, and staying home. It can have an important effect! @kamerlinlab @IDSAInfo https://t.co/seCqXwv9a9
— Peter Kasson (@kassonlab) July 2, 2020
The majority of antibiotics are used in the community. #AMS is essential in #GeneralPractice as well as acute care. Read the latest chapter in #AntimicrobialStewardship in Australian Health Care: https://t.co/UohF5iIapX @RACGP @NPSMedicineWise #KeepAntibioticsWorking #PrimaryCare pic.twitter.com/ZF6xYPE45j
— ACSQHC (@ACSQHC) July 2, 2020
🚨🚨 @accpinfdprn is teaming up with @sidp & @CLSI_LabNews for this 🔥 annual webcast on incorporating new @CLSI_LabNews recommendations into stewardship practice w/ @schuetz_audrey & Dr. Natasha Pettit!!
— ACCP INFD PRN (@accpinfdprn) July 2, 2020
🗓️Wed 7/14 from 12-1PM CT
Register NOW!🤓 https://t.co/dzz561Y59h
Check out the July issue of the International Journal of Infectious Diseases #IJID #InfectiousDiseases #OpenAccess #COVID19 #SARSCoV2 #coronavirus #pandemic #SARS #pertussis #vaccination #AMR #HIV #pneumonia # @IDAdvance https://t.co/i1cjYagmTR pic.twitter.com/FLLNnH0eRt
— ISID (@ISID_org) July 2, 2020
What a landmark! Proud of @AKUGlobal, my Peds dept & my infectious diseases section which produced the first @NEJM publication of AKU's history where all authors from @AKUGlobal & Pakistan! Well done @FyezahJehan @imran_nisar @AnitaEDD & other co-authors. https://t.co/3ak35Ew01x
— Asad Ali MBBS, MPH (@drsyedasad) July 2, 2020
What local experts say about study suggesting Covid-19 was detected long before the Wuhan outbreak | @Health24com https://t.co/vFybxRgdSh pic.twitter.com/VdBcfJ1vvi
— News24 (@News24) July 2, 2020
There’s still plenty time to join the latest run of our Antifungal Stewardship online course! This course is accredited for 9 CPD points, and has excellent relevant case studies to contextualise your learning.#AntifungalAMShttps://t.co/csXM78XKS4 pic.twitter.com/ifMVWT1EJr
— BSAC (@BSACandJAC) July 2, 2020
Influenza Virus Glycoprotein-reactive Human Monoclonal Antibodies.
— Microbes&Infection (@MicrobesInfect) July 2, 2020
Figure below shows epitope overview of mAbs targeting #influenza virus glycoproteinshttps://t.co/BGX0Rxm6D7 #flu pic.twitter.com/aeotSZHXsc
Want to come and join our #AntimicrobialStewardship team @UHP_NHS ? We have 2 new posts, to help us deliver our programme across the trust.
— Rosie Fok (@docfok) July 2, 2020
Band 4 Data Analyst and Administrator
Band 2 Surveillance Assistant
Check out the adverts https://t.co/SBEEIRxjErhttps://t.co/cu4r1hrSCN
Reopening Colleges and Universities During the COVID-19 Pandemichttps://t.co/6BU42yMzCE
— Professor Mark Wrighton (@ProfWrightonWU) July 2, 2020
I was fortunate to be able to collaborate with Dr. Steven J. Lawrence, an expert in the area of infectious diseases, to prepare this Editorial for the Annals of Internal Medicine.
What's it like to be at the @NIH these days?@DrJoshS spoke with Dr. Emily Erbelding, the director of the Division of Microbiology and Infectious Diseases at @NIAIDNews (and a @JHU_Alumni!), to find out.
— Johns Hopkins Bloomberg School of Public Health (@JohnsHopkinsSPH) July 2, 2020
#️⃣ #COVID19 #coronavirus
🎧 https://t.co/7dpWLg1ohA pic.twitter.com/XOUxrwJWS5
Fantastic title! Early Oral Antibiotic Switch for Staphylococcus aureus Bacteremia: Many Are Called, but Few Are Chosen https://t.co/6R4qXBCRjc
— Chris Bland (@blandman19) July 2, 2020
The #coronavirus pandemic in US has led to 1000s more deaths than expected from heart disease & other medical conditions.
— Microbes&Infection (@MicrobesInfect) July 2, 2020
Many patients suffering from serious conditions died as a result of not seeking care as outbreak progressed & swamped some hospitalshttps://t.co/65WMPMZxlX
Breaking News: From International Journal of Infectious Diseases: #Covid19 hospitalized patient study👇
— Jane Bailey (AcadiaU MtA)🇨🇦🇬🇧 (@peakpilot) July 2, 2020
"#Hydroxychloroquine provided a 66% hazard ratio reduction, and hydroxychloroquine + azithromycin 71% compared to neither treatment (p < 0.001)."https://t.co/XC4E56FD3p
Researchers propose an alternative approach to fight Providencia stuartii infections based on phage tailspikes with depolymerase activity that degrade the surface bacterial polymers, making the bacteria susceptible to the immune system. @AppEnvMicro https://t.co/Yy1gA3xpHj pic.twitter.com/JoPi6S5hhx
— ASM (@ASMicrobiology) July 2, 2020
To address #AntibioticResistance at country level, ReAct Africa supports countries to develop #AMR National Action Plans. #OneHealth .
— ReAct Action on ABR (@reactgroup) July 2, 2020
Learn more
https://t.co/5eDbuB6dyX
Treatment with Hydroxychloroquine and Azithromycin lowers the death rate of COVID-19 patients, latest U.S. research shows - International Journal of Infectious Diseases https://t.co/jyN6ugebc2
— BlueStateBlues (@danli_wang) July 2, 2020
Ondo health commissioner dies of COVID-19
— Gbénró Adégbolá ن (@GbenroAdegbola) July 2, 2020
Wahab Adegbenro died at the state’s infectious diseases hospital today. His death comes two days after Rotimi Akeredolu, governor of the state, announced he had tested positive for COVID- 19.https://t.co/5VFZNf2Mkz
Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19 https://t.co/SCRw3zfOJa
— ACCP INFD PRN (@accpinfdprn) July 2, 2020
"Managing COVID-19 spread with voluntary public-health measures: Sweden as a case study for pandemic control" with @kassonlab #JustAccepted in Clinical Infectious Diseases @IDSAInfo https://t.co/OR1It66O8X
— Caroline Lynn Kamerlin FCF 🇬🇧🇸🇪🇮🇷🇪🇺😷🦓 (@kamerlinlab) July 2, 2020
Biofilms will in most conditions allow phage-susceptible bacteria to be protected from phage exposure, if they are growing alongside other cells that are phage resistant. @mSystemsJ https://t.co/K3ob2lBYPw pic.twitter.com/OKqATu5zlB
— ASM (@ASMicrobiology) July 2, 2020
Chlorpromazine and Amitriptyline Are Substrates and Inhibitors of the AcrB Multidrug Efflux Pump. Good to see this published @BethGrimsey and my team 😀 @mbiojournal https://t.co/PsGiAaW5Pi
— Laura Piddock (@LauraPiddock) July 2, 2020
How effective is wearing a mask?
— Microbes&Infection (@MicrobesInfect) July 2, 2020
A microbiologist coughs, talks, sings & sneezes in to culture plates without a mask on & with a #mask on, indoors. He uses bacteria to demonstrate how much respiratory droplets can spread without a mask on.https://t.co/jPMZ7kqFp5 #Masks
ICU beds are expensive to maintain--they typically run fairly full. Not all of these people in ICUs have the virus. ICUs are used for many diseases. 675 ICU beds right now are used by COVID patients out of about 1600 ICU beds statewide.
— Rae 🔥 (@FiatLuxGenesis) July 2, 2020
Here's the data. https://t.co/3Z7S5dDsC9
Here's some good news: "initiative reduced vancomycin use in patients by 66%, and the NICU has sustained the reduction for more than a year." https://t.co/O6MH0e4v6P #AntibioticResistance
— Battle Superbugs (@battlesuperbugs) July 2, 2020
Review Series: Mechanisms underlying latency in #InfectiousDiseases: https://t.co/FxgPXTVf1l
— Journal of Clinical Investigation (@jclinicalinvest) July 2, 2020
This series conceptualized by JCI’s Deputy Editor @ACasadevall1 highlights the latency mechanisms employed by #herpesviruses, #HIV, Cryptococcus neoformans, and Toxoplasma gondii. pic.twitter.com/kz4UwD9FY6
"The pace at which things are moving is much faster than probably any previous vaccine development effort," says Dr. Emily Erbelding, director of the Division of Microbiology and Infectious Diseases at @NIAIDNews.
— Public Health On Call (@PublicHealthPod) July 2, 2020
Hear more about @NIH's work on #COVID19: https://t.co/FK1P0Cw0oz pic.twitter.com/sTP51btl1Z
An exciting opportunity has arisen for an enthusiastic, flexible and motivated Pharmacy Support Worker at @KettGeneral to join the friendly pharmacy-based Antimicrobial Stewardship Team. Learn more - https://t.co/dnI04L8h6J #TeamKGH #NHS pic.twitter.com/c7KSPjNxlW
— Best of Both Worlds (@BoBWorldsNN) July 2, 2020
Versatope Therapeutics, Inc, a biotechnology company developing vaccines and therapeutics, announced it is expanding its platform to develop a coronavirus vaccine for multiple strains https://t.co/qviCK2zKhK #vaccines #infectiousdiseases @VersatopRX pic.twitter.com/hz4IVLg9TT
— Versatope Therapeutics (@VersatopeRx) July 2, 2020
FDA Approves Fostemsavir for At-Need Adults with HIV https://t.co/gR5ZRrxHOO via @Contagion_Live
— Carlos del Rio (@CarlosdelRio7) July 2, 2020
Sweden and @UNDPGeorgia supporting @NCDCGeorgia to boost healthcare with digital solutions. New e-learning system will enable 4.000 medical staff to improve skills in treating infectious diseases.#FundedBySweden
— Ulrik Tideström 🇸🇪 (@UTidestrom) July 2, 2020
@SwedeninGE https://t.co/1cgX0yTRke
If you think covid is a dangerous, deadly virus, this may be of interest to you.
— Laura (@LauraLoquacious) July 2, 2020
Or more accurately, the fact covid is missing from the list should reassure you.
Screenshot from the government website -
List of high consequence infectious diseaseshttps://t.co/lHzHbUFcpA pic.twitter.com/tvIVF2RiT5
Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19 - International Journal of Infectious Diseases https://t.co/2xTJgvF7aH
— ❌Joe FreedomLover❌🇺🇸🇺🇸🇺🇸 (@JoeFreedomLove) July 2, 2020
Tackling #antimicrobial resistance in the #COVID19 pandemic https://t.co/rnpv87HRo8
— Debbie Goff (@idpharmd) July 2, 2020
Tufts Medical Center Chief of Infectious Diseases Dr. @hboucher3 made an appearance on the @NBCSBoston Next Pats Podcast to discuss the return of professional sports and if/how it can be done safely. https://t.co/a3cYBMPoFn #coronavirus #COVID19
— Tufts Medical Center (@TuftsMedicalCtr) July 2, 2020
The Aga Khan Health Services Tanzania in partnership with the French Development Agency signed a €300,000 grant agreement to establish infectious diseases units in the hospitals of Dar es Salaam and Mwanza. Read here for more https://t.co/ifdIxt15xZ #AKHS #AKDN
— AKDN (@akdn) July 2, 2020
”'We need to absolutely, 100% flatten the curve right now,' Dr. Edward Stenehjem, an infectious diseases specialist with Intermountain....'We cannot tolerate a big surge after a July 4 holiday.We just can’t....We don’t have the hospital capacity to do it.' https://t.co/63n3JlWoJQ
— Elizabeth Pinborough 🏡 (@epinborough) July 2, 2020
"This is the pandemic of a lifetime," says Dr. Emily Erbelding, director of the Division of Microbiology and Infectious Diseases at @NIAIDNews.
— Johns Hopkins Bloomberg School of Public Health (@JohnsHopkinsSPH) July 2, 2020
In this episode of @PublicHealthPod, @DrJoshS talks to Dr. Erbelding about the @NIH's work on #COVID19.
🎧 https://t.co/7dpWLg1ohA pic.twitter.com/t4KKfIqecd
Thus, #Antimicrobial #Stewardship Teams are a valuable part of #hospital safety & quality to help stop the spread of #COVID19 & to identify & treat secondary bacterial infections.
— EAHP (@EAHPtweet) July 2, 2020
EAHP's position paper on antimicrobial resistance :https://t.co/lU0dwNM17c pic.twitter.com/Lv12rq5GlU
Implementing an #antibiotic stewardship program is one meaningful way a hospital can take part in the fight against #superbugs. https://t.co/l9U9IPh5YQ
— Save Antibiotics (@saveantibiotics) July 2, 2020
Infection Rate in the Greater Houston Area - Much to be learned from Texas Medical Center #COVIDー19 dashboard. Very well done with clear, up-to-date and transparent information. @drsanjaygupta https://t.co/U8ByLjerav
— Carlos del Rio (@CarlosdelRio7) July 2, 2020
According to new @CDCGov data, fewer than half of #COVID19 patients are aware of recent close contact w/ someone who’s infected.
— IDSA (@IDSAInfo) July 2, 2020
W/ so many U.S. regions experiencing community spread, it’s important to protect yourself & others over the holiday wkend. https://t.co/GymBC7IUaC pic.twitter.com/zksuOXfEch
It's science — factors at play in bars make them potential virus flashpoints, says Natalie Dean, an infectious diseases expert at the University of Florida. Alcohol lowers inhibitions, so people forget precautions.https://t.co/COr3q5tsnx
— TribLIVE.com (@TribLIVE) July 2, 2020
New paper by Kari-Anne Heald et al. on prevalence of infectious diseases in polecats in Britain. Read more here: https://t.co/fFBhbOtdm7 pic.twitter.com/wCkBbJ0ous
— Dr Katie Sainsbury (@ktsainsbury1) July 2, 2020
Study: Many in US distanced before states mandated it #COVID19 https://t.co/9Qn4Vf10lv pic.twitter.com/4egrGR4cOA
— CIDRAP (@CIDRAP) July 2, 2020
Estimation of Excess Deaths Associated With the COVID-19 Pandemic in the United States, March to May 2020 | Infectious Diseases | JAMA Internal Medicine | JAMA Network https://t.co/ifI1quhQDJ
— Zainab Shahid (@ZainabShd) July 2, 2020
Antimicrobial resistance of Streptococcus suis isolates recovered from clinically ill nursery pigs and from healthy pigs at different stages of production. https://t.co/95lvrdzh1m
— AntibioticResistance (@AntibioticResis) July 2, 2020
HADRIANS HOSPITAL, WALLSEND. Situated close to the Coast Road, this Infirmary was once a specialist infectious diseases hospital, likely dealing with TB and Typhoid. Nothing remains of the site, and is now the Kings Vale housing development. https://t.co/efI5jJO4KB pic.twitter.com/8hxgD6rYik
— North East Heritage Library (@neheritagelib) July 2, 2020
The plant pathogen P. infestans exists as a sexual population, or a clonal lineage. Sexual populations at the center of origin are diploid, whereas populations elsewhere are more variable w/ genome-wide variation in gene copy number @mBiojournal https://t.co/mlPkzpbRFE pic.twitter.com/yBdRcA7nv0
— ASM (@ASMicrobiology) July 2, 2020
"..a single-dose of gentamicin in patients with sepsis in the ED is safe with regard to renal function." True, but review *after* the 1st dose is the problem for #AKI development @renalpages @ItishaG https://t.co/cQZNuKcZgk
— Abid Hussain (@MicrobLog_me_uk) July 2, 2020
Great study showing in young healthy females with recurrent symptomatic UTI - treating asymptomatic bacteruria actually INCREASED the frequency of symptomatic UTI. YOU MAY BE PREDISPOSING TO A UTI TREATING A LAB RESULT AND NOT THE PATIENT. 7/https://t.co/6aWxIVn9Iw
— Zain Chagla (@zchagla) July 2, 2020
.@CIDRAP weekly resistance scan published yesterday. Be sure to give it read an sign up for it if you don't already receive it. https://t.co/Bz8kisaX5e #AntibioticResistance pic.twitter.com/NYQvCEEV6w
— Battle Superbugs (@battlesuperbugs) July 2, 2020
The challenge is most of these are viral. Need to treat 44 for benefit beyond placebo. There’s a need for bio markers to differentiate children that actually need antibiotics. https://t.co/GYFvifu1gH
— Kevin Schwartz (@DrKevinSchwartz) July 2, 2020
Science Director of the Science Museum Group, @roger_highfield, in conversation with the Chair of Infectious Diseases at Imperial College London, Ajit Lalvani, recently recovered from #coronavirus & talks about #COVID19 pandemic. Tune in https://t.co/nTHaHF1Qi7 #JLFBraveNewWorld pic.twitter.com/3layAUO4w8
— RedFMIndia (@RedFMIndia) July 2, 2020
Why Antimicrobial Stewardship https://t.co/sS99vvXj2P via @YouTube @AmityUni @ErasmusMC
— Harsha Kharkwal (@KharkwalHarsha) July 2, 2020
#idtips #idmeded D2. Asymptomatic bacteruria. Excellent guide by @idsa and @RSiemieniuk . Takeaways are consider pop'n you are doing the test on, and don't order it if UTI isn't in differential diagnosis. Urinalysis is also frequently misleading 1/https://t.co/qxJe91AuQa
— Zain Chagla (@zchagla) July 2, 2020
@JAMA_current 7.2.20 | #JAMALive: U.S. #Coronavirus #Update: #AnthonyFauci, MD, White House Coronavirus Task Force member and Director of the National Institutes of Allergy and Infectious Diseases, discusses latest developments in the COVID-19 pandemic.~~https://t.co/faQe7wZ1sw
— Martha Jane Adams (@marthajadams) July 2, 2020
Another great recent study to read and digest! Early Release - Culture-Competent SARS-CoV-2 in Nasopharynx of Symptomatic Neonates, Children, and Adolescents - Volume 26, Number 10—October 2020 - Emerging Infectious Diseases journal - CDC https://t.co/vLHSyHRcZF
— Rob Bruns (@SciTeachMidMO) July 2, 2020
Dr #AnthonyFauci warns that spread of #COVID19 "could get very bad" if people fail to take countermeasures, pinning hopes on a vaccine. There is "no guarantee of a (working) vaccine," says the top US infectious diseases expert. https://t.co/qw9EqtNDVd
— Tech2 (@tech2eets) July 2, 2020
IFPMA members have worked for 20 years with @GAVI to stem the spread of preventable infectious diseases around the world. Now they collaborate to bring a #COVID19 vaccine as quickly as possible to the world. #LeaveNoOneBehind #VaccinesWork@ThomasCuenihttps://t.co/dyYtihXNh1
— IFPMA (@IFPMA) July 2, 2020
Study strongly supports a role of social distancing as an effective way to mitigate COVID-19 transmission - The Lancet Infectious Diseases https://t.co/Hi2vXlIlpZ pic.twitter.com/7DOx8u3gUx
— Thomas Higgins, M.D. (@DrThomasHiggins) July 2, 2020
Researchers identify a gut #microbiome profile that could be used to detect #liver fibrosis & cirrhosis with an accuracy of greater than 90%.https://t.co/CSgAGC3lY2 #microbiota #NAFLD
— Microbes&Infection (@MicrobesInfect) July 2, 2020
#Flu season may be ‘devastating,’ officials warn https://t.co/rNsbZ9QQND via @mcknightsltcn with #NFID Medical Director William Schaffner, MD pic.twitter.com/jaBs9hg6u7
— NFID (@NFIDvaccines) July 2, 2020
Absolutely critical that #COVID19 vaccines are trialed in our local context. Looking forward to a site opening in Cape Town. Will be first in line! @PresidencyZA @DrZweliMkhize @ShabirMadh @MRCza @SAHPRA1https://t.co/miwN01Vdyf
— Marc Mendelson (@SouthAfricanASP) July 2, 2020
Estimation of Excess Deaths Associated With the COVID-19 Pandemic in the United States, March to May 2020 | Infectious Diseases | JAMA Internal Medicine | JAMA Network #WearAMask https://t.co/TuNNb8MqL5
— Nicole (@NicoleAsh0703) July 2, 2020
This coronavirus mutation has taken over the world. Scientists are trying to understand why. https://t.co/SmaMvpOYDJ
— Chris Bland (@blandman19) July 2, 2020
A strong, well-funded public health infrastructure is essential for combating public health threats, including #COVID19 and #antibioticresistance. https://t.co/m5YV5yQRxr
— Save Antibiotics (@saveantibiotics) July 2, 2020
Association between mobility patterns and #COVID19 transmission in the USA: a mathematical modelling study - The Lancet Infectious Diseases - https://t.co/AGKxeBGCap
— Novel Coronavirus - Covid19 (@PandemicCovid20) July 2, 2020
Check out this new @livablefuture resource for policymakers, advocates, and others working to address to address the impacts of #CAFOs in their communities. https://t.co/eUotu3Ny2m #AntibioticResistance
— Battle Superbugs (@battlesuperbugs) July 2, 2020
Wow, this says that 90% of penicillin allergies are not able to be confirmed. https://t.co/tba7Kzadbx #AntibioticResistance
— Battle Superbugs (@battlesuperbugs) July 2, 2020
“We’ve had young, young infants in the hospital. We’ve also had older children as well,” said Dr. David Kimberlin, a pediatric infectious diseases physician at Children’s of Alabama. #COVID19 https://t.co/Y0Pull9rmP
— Lauren Walsh (@LaurenWalshTV) July 2, 2020
The impact of antimicrobial stewardship program implementation at four tertiary private hospitals: results of a five-years pre-post analysis. https://t.co/HESXQB8Lnr #cdiff #cdi
— Dave Roberts (@CDifficile1) July 2, 2020
Estimation of Excess Deaths Associated With the #COVID19 Pandemic in the United States, March to May 2020 | Infectious Diseases | JAMA Internal Medicine | JAMA Network - https://t.co/MR46n64fIV
— Novel Coronavirus - Covid19 (@PandemicCovid20) July 2, 2020
Estimation of Excess Deaths Associated With the COVID-19 Pandemic in the United States, March to May 2020 | Infectious Diseases | JAMA Internal Medicine | JAMA Network https://t.co/KY9nRW7kAp
— The Goat (@Mr_Jitters) July 2, 2020
How long can the SARS-CoV-2 virus linger in the air? How much do masks protect you? Watch the latest UCDavis #COVID19 Live featuring William Ristenpart, professor of chemical engineering and Dean Blumberg, Chief of Pediatric Infectious Diseases https://t.co/Ql3A2x9gJm pic.twitter.com/qXVncKT98h
— UC Davis Research (@UCDavisResearch) July 2, 2020
In addition to antivirals, @NIH is also testing host mediating factors that limit inflammation, says Dr. Emily Erbelding, director of the Division of Microbiology and Infectious Diseases at @NIAIDNews.
— Public Health On Call (@PublicHealthPod) July 2, 2020
Hear about NIH's #COVID19 work on this episode.
🎧 https://t.co/FK1P0Cw0oz pic.twitter.com/iLEjv4vHFt
I’m sorry, but saying we would never apply it to an outbreak setting, and then releasing this press release saying asymptomatic workers can work directly citing the Windsor outbreak is not the same messaging. https://t.co/GlNmLl8qBo https://t.co/FAI09uveyh
— Zain Chagla (@zchagla) July 2, 2020
New preprint on @Science_Open "Assessing the infection burden and associated risk factors in children under 5 across Jaipurs urban slums". Read and openly review the #openaccess article #shareyourexpertise #India #pollution #infectiousdiseases #covid19 https://t.co/dExSQUiZqv pic.twitter.com/xpmz104rRe
— UCL Open: Environment (@uclopen_env) July 2, 2020
The situation update on #coronavirus has been updated on our website (2 July at 16:00).
— THL (@THLorg) July 2, 2020
🔹Samples tested: approx. 248,900
🔹Reported cases: 7,241
🔹Recovered: approx. 6,700
Read more 👇 https://t.co/sdGQYvL8Wx
What is Contact Tracing? Contact tracing is a process that is used to identify, educate & monitor individuals who have had close contact with someone who is infected with a virus. Loop's #technology will assist this effort! Learn more about tracing here https://t.co/6gEcwL3rg0
— Loop Insights (@LoopInsights) July 2, 2020
“Data is converging on the idea that it’s best to give #plasma to [#COVID19] patients who are less ill….it averts transmission from an early type of respiratory disease to one that is [more severe.]” Dr. Liise-Anne Pirofski of @EinsteinMed.
— IDSA (@IDSAInfo) July 2, 2020
🎧: https://t.co/93zSRtCF8u pic.twitter.com/eekBR8wSht
Browse hundreds of ePosters from your peers covering the latest research in the microbial sciences. Access to all #ASMMicrobeOnline ePosters is now open at https://t.co/nmZUaSRpVz pic.twitter.com/nCH8mgpjPp
— ASM (@ASMicrobiology) July 2, 2020
#SynbiTECHLive will review the ongoing #pandemic from both UK and US standpoints, with insights from leading global experts in #epidemiology, #InfectiousDiseases and #vaccine technology. It's not too late to register: https://t.co/YgrZ5rG84L #SynBio #COVID19
— SynbiCITE (@SynbiCITE) July 2, 2020
By targeting conserved regions of the influenza virus, Versatope aims to develop a one-time universal flu vaccine https://t.co/qviCK2zKhK #vaccines #infectiousdiseases @VersatopRX pic.twitter.com/tC9T12UHDi
— Versatope Therapeutics (@VersatopeRx) July 2, 2020
Coronavirus vaccine tracker: How close are we to a vaccine? https://t.co/8vow01TUST
— Elizabeth Beech MBE (@elizbeech) July 2, 2020
Indus Hospital's first weekly LIVE digital show ‘Sehat Sab Ke Liye/Health for All’ on iHealth TV
— The Indus Hospital (@indus_hospital) July 2, 2020
Dr. Abdul Bari Khan, CEO #IndusHealthNetwork & Dr. Samreen, Consultant Infectious Diseases #TheIndusHospital, on #COVID19 Myths. 3rd July @ 4pm
Subscribe: https://t.co/s3ZnC4Ua8k pic.twitter.com/XXYuE9zkxZ
NEW Perspective @NEJM by
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) July 2, 2020
Dr. Anthony Fauci
Four Decades of HIV/AIDS — Much Accomplished, Much to Dohttps://t.co/F8lHDMnBZD pic.twitter.com/DIM9zZQ3bU
National French survey of COVID-19 symptoms in people aged 70 and over | Clinical Infectious Diseases | Oxford Academic https://t.co/5pRgi5u9Xm
— Christophe Trivalle (@CTrivalle) July 2, 2020
Study terminated for futility.
— Eric Macy (@EricMacyMD) July 2, 2020
16 PST ID+, only 1 OC+.
False+ PSTs.
Sensitivity and specificity of double-blinded penicillin skin testing in relation to oral provocation with amoxicillin in children | Allergy, Asthma & Clinical Immunology | Full Text https://t.co/iPgWXkmmJo
Thanks to reader hint: "@kerrymGilmore directed @cenmag to artemisiaannua. org. It claims “a powerful body of scientific evidence has revealed"... Artemisia annua highly active against a broad range of human diseases, incl viruses, parasites, and cancers.” https://t.co/dNLD1erzFN
— Leonid Schneider (visit my site for Covid19 cures) (@schneiderleonid) July 2, 2020
COVID mortality varied dramatically between NYC hospitals - even in the same health systems, even next-door
— Infectious Diseases (@InfectiousDz) July 2, 2020
Hospitals, even next-door, have different catchment areas, care delays, underlying conditions in populations served, but this is worth readinghttps://t.co/ePu3q6u7T6
NEWS SCAN: #Ebola in the DRC; N95 respirator decontamination; Vaccine candidate shows early promise; Stroke risk in #COVID19 https://t.co/xRDVZV4AZJ
— CIDRAP (@CIDRAP) July 2, 2020
"..with non-severe COVID-19, viral loads in upper respiratory specimens peak by two or three days from symptom onset and decrease rapidly thereafter." https://t.co/uHs15JlMAG @ItishaG
— Abid Hussain (@MicrobLog_me_uk) July 2, 2020
#Covid19 “Several studies show that you can grow the virus in a test tube and then kill it off with high doses of various drugs we already have,” says Pranay Sinha, an infectious diseases physician and researcher at Boston Medical Center in Boston https://t.co/btN4A4BMmS
— Ojo-Publico. com (@Ojo_Publico) July 2, 2020
A very thoughtful editorial on a JAMA study looking at excess deaths during the first weeks of the pandemic. I liked the editorial more than the study itself. Mortality and Morbidity: The Measure of a Pandemic | Infectious Diseases | JAMA | JAMA Network https://t.co/KmMk7uXDy6
— Dominik Mertz (@DocDominik) July 2, 2020
SARS-CoV-2 infection in healthcare personnel with high-risk occupational exposure: evaluation of seven-day exclusion from work policy https://t.co/0d7Y4D69Gu
— Abid Hussain (@MicrobLog_me_uk) July 2, 2020
Sewage surveillance seen as a promising way of identifying future disease hotspots: “#Wastewater could effectively become the canary in the coal mine for #COVID19 & other emerging infectious diseases” @OxonAndrew @UK_CEH https://t.co/kvReCuH3L2 #NWESP pic.twitter.com/ZXwU9V8Og6
— UK Centre for Ecology & Hydrology (@UK_CEH) July 2, 2020
Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19 - International Journal of Infectious Diseases https://t.co/32rjqIBkax
— Donny Clark⭐⭐⭐ (@Clark51Austin) July 2, 2020
although we have a delay effect because infected individuals might need hospitalisation only later in the course of their diseases.'
— Paula Bergman PhD Vet.Epi 🇫🇮🇳🇴🇬🇧🇩🇪🇸🇪🇩🇰 (@bergman_paula) July 2, 2020
R-estimointia&koko mallia on myös jatkuvasti päivitetty. 2/2https://t.co/uyqNE5V1lA pic.twitter.com/zMx9unKEhG
Alcohol lowers inhibitions, so people forget precautions, said Natalie Dean, an infectious diseases expert. https://t.co/Zg0asiaGG8
— News 6 WKMG (@news6wkmg) July 2, 2020
More proof that face masks can help curb the spread of #coronavirus https://t.co/n8odLqZskB
— Board of Healthcare Funders (@BHFGLOBAL) July 2, 2020
Moving Personal Protective Equipment Into the Community: Face Shields and Containment of COVID-19 | Infectious Diseases | JAMA | JAMA Network https://t.co/IE6s56qvvI
— IE Alumni Geneva (@IEAlumni_Geneva) July 2, 2020
Researchers at Boston University’s National Emerging Infectious Diseases Laboratories and University of California, San Diego, found that nano sponges can act as decoys to distract and neutralize SARS COV2, which may have applications for other viruses. https://t.co/LqNaRBuJ91
— Altasciences (@Altasciences) July 2, 2020
Stubborn partygoers obstruct #PublicHealth investigation into #coronavirus so officials brandish subpoenas
— Tim Lahey (@TimLaheyMD) July 2, 2020
I get the temptation but we could lose more community trust if contact tracing is too aggressive https://t.co/njw0YrDUc4
The availability of vaccines has encouraged a belief that infectious diseases are a thing of the past. During the second half of the 20th century, much of the US’s disease prevention infrastructure crumbled. A new @RetroReport has the story:https://t.co/W2uxQU6BO8
— Retro Report (@RetroReport) July 2, 2020
Created by Cameron Forbes. Last updated July 09, 2020 at 05:08 EST.